Gaipa, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.383
EU - Europa 2.373
AS - Asia 1.262
SA - Sud America 66
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 9.112
Nazione #
US - Stati Uniti d'America 5.298
SG - Singapore 495
IT - Italia 482
CN - Cina 431
SE - Svezia 383
DE - Germania 355
IE - Irlanda 305
RU - Federazione Russa 275
UA - Ucraina 164
GB - Regno Unito 126
HK - Hong Kong 122
CA - Canada 80
BR - Brasile 59
VN - Vietnam 59
FI - Finlandia 57
BE - Belgio 51
IN - India 46
TR - Turchia 39
DK - Danimarca 37
ID - Indonesia 37
FR - Francia 33
NL - Olanda 26
AT - Austria 20
EU - Europa 11
CZ - Repubblica Ceca 9
RO - Romania 8
ES - Italia 7
IR - Iran 6
AU - Australia 5
GR - Grecia 5
NO - Norvegia 5
KR - Corea 4
MX - Messico 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EG - Egitto 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NG - Nigeria 3
PK - Pakistan 3
RS - Serbia 3
AR - Argentina 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
JP - Giappone 2
LT - Lituania 2
MU - Mauritius 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.112
Città #
Ann Arbor 1.404
Woodbridge 454
Chandler 390
Fairfield 378
Wilmington 354
Singapore 311
Dublin 296
Houston 289
Frankfurt am Main 231
Ashburn 225
Jacksonville 180
Dearborn 157
Milan 149
Seattle 148
New York 123
Cambridge 122
Hong Kong 119
Princeton 99
Santa Clara 82
Shanghai 78
Nanjing 65
Altamura 53
Brussels 47
Lawrence 47
Lissone 44
Beijing 37
Fremont 35
Jakarta 34
San Diego 33
Council Bluffs 30
Lachine 30
Dong Ket 29
Hangzhou 26
Helsinki 25
Boardman 24
Guangzhou 24
Nanchang 22
Toronto 22
Moscow 19
Kocaeli 18
Los Angeles 18
Jinan 17
Vienna 17
Andover 16
Hebei 16
Tianjin 16
Shenyang 15
Nuremberg 14
London 12
Ottawa 12
Edmonton 11
Kunming 11
Ningbo 11
Pune 11
Monza 10
Mountain View 10
Zhengzhou 10
Jiaxing 9
Munich 9
Redmond 9
Göttingen 7
Norwalk 7
Rome 7
Taizhou 7
Turin 7
Besana In Brianza 6
Chicago 6
Falls Church 6
Huizen 6
Auburn Hills 5
Changsha 5
Kiev 5
Madrid 5
San Mateo 5
Belo Horizonte 4
Brookline 4
Dallas 4
Desio 4
Hefei 4
Mumbai 4
Nürnberg 4
Padova 4
Prague 4
Sacramento 4
São Paulo 4
West Jordan 4
Wuhan 4
Brno 3
Brugherio 3
Cairo 3
Carate Brianza 3
Colombo 3
Faisalabad 3
Gap 3
Grafing 3
Lecco 3
Napoli 3
Oslo 3
Pozzuolo Martesana 3
Rho 3
Totale 6.682
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 335
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 326
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 321
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 299
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 292
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 286
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 272
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 265
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 259
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 258
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 244
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 242
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 241
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 236
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 223
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 217
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 215
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 210
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 208
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 207
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice 181
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 178
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 178
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 176
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 170
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 169
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 169
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 169
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 167
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 165
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 164
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 164
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 161
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 161
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 151
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 150
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 145
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 144
Noonan Syndrome Peripheral Blood Cells Show Enhanced Spontaneous Colonies Growth In Vitro and Hyperactive JAK and RAS Intracellular Signalling Pathways 144
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 144
Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling 128
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 125
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 115
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 114
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 106
Monitoring of minimal residual disease in leukemia, advantages and pitfalls 92
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies 92
Linking cell function with perfusion: Insights from the transcatheter delivery of bone marrow-derived CD133 + cells in ischemic refractory cardiomyopathy trial (RECARDIO) 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 82
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 67
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 65
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 53
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 48
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 37
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 25
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining 22
Totale 9.577
Categoria #
all - tutte 33.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020265 0 0 0 0 0 0 0 0 0 108 116 41
2020/20211.634 47 112 206 176 137 139 149 107 135 177 93 156
2021/2022986 99 116 114 75 56 75 41 49 91 85 69 116
2022/20231.460 153 476 107 144 71 209 37 85 100 9 43 26
2023/2024962 29 29 48 54 134 246 185 32 53 26 18 108
2024/20251.360 102 192 90 105 187 95 89 86 278 136 0 0
Totale 9.577